Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) announced the appointment of Andrew Dreyfus, president and chief executive officer of Blue Cross Blue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE